Literature DB >> 21074618

Expression and purification of soluble murine CD40L monomers and polymers in yeast Pichia pastoris.

Christina E Hermanrud1, Carrie L Lucas, Megan Sykes, Christene A Huang, Zhirui Wang.   

Abstract

The anti-murine CD40L monoclonal antibody MR1 has been widely used in immunology research to block the CD40-CD40L interaction for induction of transplantation tolerance and to abrogate autoimmune diseases. The availability of recombinant CD40L with high binding capacity for MR1 would provide a valuable immunologic research tool. In this study, we constructed the single chain murine soluble CD40L monomer, dimer, trimer and successfully expressed them in yeast Pichia pastoris under the control of the alcohol oxidase promoter. The secreted single chain murine soluble CD40L monomers, dimers, and trimers were initially enriched through histidine tag capture by Ni-Sepharose 6 fast flow resin and further purified on a cation exchange resin. Purity reached more than 95% for the monomer and dimer forms and more than 90% for the trimer. Protein yield following purification was 16 mg/L for the monomer and dimer, and 8 mg/L for the trimer. ELISA analysis demonstrated that the CD40L dimers and trimers correctly folded in conformations exposing the MR1 antigenic determinant.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21074618      PMCID: PMC3005846          DOI: 10.1016/j.pep.2010.11.006

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  18 in total

Review 1.  CD40/CD154 interactions at the interface of tolerance and immunity.

Authors:  Sergio A Quezada; Lamis Z Jarvinen; Evan F Lind; Randolph J Noelle
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

2.  Improved binding of a bivalent single-chain immunotoxin results in increased efficacy for in vivo T-cell depletion.

Authors:  J Thompson; S Stavrou; M Weetall; J M Hexham; M E Digan; Z Wang; J H Woo; Y Yu; A Mathias; Y Y Liu; S Ma; I Gordienko; P Lake; D M Neville
Journal:  Protein Eng       Date:  2001-12

Review 3.  CD40-CD40 ligand.

Authors:  C van Kooten; J Banchereau
Journal:  J Leukoc Biol       Date:  2000-01       Impact factor: 4.962

4.  Antigen-specific interaction between T and B cells.

Authors:  A Lanzavecchia
Journal:  Nature       Date:  1985 Apr 11-17       Impact factor: 49.962

5.  CD40 ligand has potent antiviral activity.

Authors:  J Ruby; H Bluethmann; M Aguet; I A Ramshaw
Journal:  Nat Med       Date:  1995-05       Impact factor: 53.440

6.  A 3-D model for the CD40 ligand predicts that it is a compact trimer similar to the tumor necrosis factors.

Authors:  M C Peitsch; C V Jongeneel
Journal:  Int Immunol       Date:  1993-02       Impact factor: 4.823

7.  Gene optimization is necessary to express a bivalent anti-human anti-T cell immunotoxin in Pichia pastoris.

Authors:  Jung Hee Woo; Yuan Yi Liu; Askale Mathias; Scott Stavrou; Zhirui Wang; Jerry Thompson; David M Neville
Journal:  Protein Expr Purif       Date:  2002-07       Impact factor: 1.650

8.  Earlier low-dose TBI or DST overcomes CD8+ T-cell-mediated alloresistance to allogeneic marrow in recipients of anti-CD40L.

Authors:  Yasuo Takeuchi; Hiroshi Ito; Josef Kurtz; Thomas Wekerle; Leon Ho; Megan Sykes
Journal:  Am J Transplant       Date:  2004-01       Impact factor: 8.086

9.  Human native soluble CD40L is a biologically active trimer, processed inside microsomes.

Authors:  F Pietravalle; S Lecoanet-Henchoz; H Blasey; J P Aubry; G Elson; M D Edgerton; J Y Bonnefoy; J F Gauchat
Journal:  J Biol Chem       Date:  1996-03-15       Impact factor: 5.157

10.  Separation of bivalent anti-T cell immunotoxin from Pichia pastoris glycoproteins by borate anion exchange.

Authors:  Jung Hee Woo; David M Neville
Journal:  Biotechniques       Date:  2003-08       Impact factor: 1.993

View more
  2 in total

1.  Expression of soluble recombinant transglutaminase from Zea mays in Pichia pastoris.

Authors:  Hongbo Li; Lanwei Zhang; Yanhua Cui; Xue Luo; Chaohui Xue; Shumei Wang
Journal:  World J Microbiol Biotechnol       Date:  2013-01-08       Impact factor: 3.312

2.  Diphtheria toxin-based bivalent human IL-2 fusion toxin with improved efficacy for targeting human CD25(+) cells.

Authors:  Jaclyn Stromp Peraino; Huiping Zhang; Priyani V Rajasekera; Min Wei; Joren C Madsen; David H Sachs; Christene A Huang; Zhirui Wang
Journal:  J Immunol Methods       Date:  2014-01-24       Impact factor: 2.303

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.